132 related articles for article (PubMed ID: 27430395)
41. Selection of women at risk for cervical cancer in an HIV-infected South African population.
Van Zummeren M; Kremer WW; Van Aardt MC; Breytenbach E; Richter KL; Rozendaal L; Witte BI; De Strooper LMA; Hesselink AT; Heideman DAM; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
AIDS; 2017 Sep; 31(14):1945-1953. PubMed ID: 28692545
[TBL] [Abstract][Full Text] [Related]
42. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
43. HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant.
van der Weele P; King AJ; Meijer CJLM; Steenbergen RDM
Papillomavirus Res; 2019 Jun; 7():168-172. PubMed ID: 30991124
[TBL] [Abstract][Full Text] [Related]
44. Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
Bukowski A; Hoyo C; Vielot NA; Graff M; Kosorok MR; Brewster WR; Maguire RL; Murphy SK; Nedjai B; Ladoukakis E; North KE; Smith JS
BMC Cancer; 2023 Nov; 23(1):1072. PubMed ID: 37932662
[TBL] [Abstract][Full Text] [Related]
45. Methylation of
Meršaková S; Holubeková V; Grendár M; Višňovský J; Ňachajová M; Kalman M; Kúdela E; Žúbor P; Bielik T; Lasabová Z; Danko J
Oncol Lett; 2018 Dec; 16(6):7166-7174. PubMed ID: 30546453
[TBL] [Abstract][Full Text] [Related]
46. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
47. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
[TBL] [Abstract][Full Text] [Related]
48. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
49. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
[TBL] [Abstract][Full Text] [Related]
50. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
51. CyclinA1 Promoter Methylation in Self-Sampling Test.
Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
[TBL] [Abstract][Full Text] [Related]
52. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
[TBL] [Abstract][Full Text] [Related]
53. LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.
Barchitta M; Quattrocchi A; Maugeri A; Canto C; La Rosa N; Cantarella MA; Spampinato G; Scalisi A; Agodi A
BMC Cancer; 2017 Aug; 17(1):601. PubMed ID: 28854904
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
55. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
[TBL] [Abstract][Full Text] [Related]
56. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
57. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
58. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
59. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
60. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
